Loading…

Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors

Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of...

Full description

Saved in:
Bibliographic Details
Published in:Progress in transplantation (Aliso Viejo, Calif.) Calif.), 2011-09, Vol.21 (3), p.236-247
Main Authors: Shafer, Teresa J., Schkade, David, Schkade, Lawrence, Geier, Steven S., Orlowski, Jeffrey P., Klintmalm, Goran
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13
cites cdi_FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13
container_end_page 247
container_issue 3
container_start_page 236
container_title Progress in transplantation (Aliso Viejo, Calif.)
container_volume 21
creator Shafer, Teresa J.
Schkade, David
Schkade, Lawrence
Geier, Steven S.
Orlowski, Jeffrey P.
Klintmalm, Goran
description Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of donors and ruled-out potential donors who had a positive result on an HIV test from January 1, 2006, to October 31, 2008. Sixty-two percent of US organ procurement organizations participated. Of the 12397 donor/nondonor cases, 56 (0.45%) had an initial positive result on an HIV antibody or HIV nucleic acid test, and only 8 (14.3%) of those were confirmed positive. Of the false-positive results, 50% were from HIV antibody tests and 50% were from HIV nucleic acid tests. Organs are a scarce, finite, and perishable resource. Use of HIV antibody testing has produced a remarkably safe track record of avoiding HIV transmission, with 22 years of nonoccurrence between transmissions. Because false positives occur with any test, including the HIV Ab test, adding nucleic acid testing to the standard donor testing panel doubles the number of false-positive HIV test results and thus the number of medically suitable donors lost. The required HIV antibody test is 99.99% effective in preventing transmission of the HIV virus. Adding the HIV nucleic acid test to routine organ donor screening could result in as many as 761 to 1551 unnecessary deaths of patients between HIV transmission events because medically suitable organs are wasted.
doi_str_mv 10.1177/152692481102100309
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_896829840</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_152692481102100309</sage_id><sourcerecordid>896829840</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13</originalsourceid><addsrcrecordid>eNp9kctuEzEUhi0EomngBVhUFhtWQ308nozdXZXSixRRhAILNiPbY0duZ-xgj5H6DH3pOk0BqUgsjqwjf-c_lx-hd0A-ArTtMTR0ISjjAIQCITURL9CMwoJVi5bwl2i2A6odcYAOU7ohhLaMk9fogIJoW86bGbr_YWLAX126xeswmCi9NngZ0pTwyv0y6QSvQko4WLwuf2k7SD9JNRh8HTclx2fZ4CngyzxKj6_GMfvQG-u0M17f4e8u5oQ_Zz0Yp_Gpdj1emzQ5v9kpfgmT8ZOTAz4LPsT0Br2yckjm7dM7R9_OP62Xl9Xq-uJqebqqNAUmKkZkw2rCSM1ZTcsqqoQlFlplOeubRiumGhCNlr0FDgp6wjSntaqVEhbqOfqw193G8DOXebrRJW2GspsJOXVcLDgVvDSYo_fPyJuQoy_DFejxmFQUiO4hHcuporHdNrpRxrsOSLczqvvXqFJ09KSc1Wj6PyW_nSnA8R5IcmP-tv2P5APqApqa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>892748029</pqid></control><display><type>article</type><title>Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors</title><source>Sage Journals Online</source><creator>Shafer, Teresa J. ; Schkade, David ; Schkade, Lawrence ; Geier, Steven S. ; Orlowski, Jeffrey P. ; Klintmalm, Goran</creator><creatorcontrib>Shafer, Teresa J. ; Schkade, David ; Schkade, Lawrence ; Geier, Steven S. ; Orlowski, Jeffrey P. ; Klintmalm, Goran</creatorcontrib><description>Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of donors and ruled-out potential donors who had a positive result on an HIV test from January 1, 2006, to October 31, 2008. Sixty-two percent of US organ procurement organizations participated. Of the 12397 donor/nondonor cases, 56 (0.45%) had an initial positive result on an HIV antibody or HIV nucleic acid test, and only 8 (14.3%) of those were confirmed positive. Of the false-positive results, 50% were from HIV antibody tests and 50% were from HIV nucleic acid tests. Organs are a scarce, finite, and perishable resource. Use of HIV antibody testing has produced a remarkably safe track record of avoiding HIV transmission, with 22 years of nonoccurrence between transmissions. Because false positives occur with any test, including the HIV Ab test, adding nucleic acid testing to the standard donor testing panel doubles the number of false-positive HIV test results and thus the number of medically suitable donors lost. The required HIV antibody test is 99.99% effective in preventing transmission of the HIV virus. Adding the HIV nucleic acid test to routine organ donor screening could result in as many as 761 to 1551 unnecessary deaths of patients between HIV transmission events because medically suitable organs are wasted.</description><identifier>ISSN: 1526-9248</identifier><identifier>EISSN: 2164-6708</identifier><identifier>DOI: 10.1177/152692481102100309</identifier><identifier>PMID: 21977885</identifier><identifier>CODEN: PTRRBT</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>AIDS Serodiagnosis ; Cost-Benefit Analysis ; False Positive Reactions ; Health Policy ; HIV Infections - prevention &amp; control ; HIV Infections - transmission ; Humans ; Nucleic Acid Amplification Techniques ; Risk Assessment ; Tissue and Organ Procurement ; Tissue Donors - supply &amp; distribution ; United States</subject><ispartof>Progress in transplantation (Aliso Viejo, Calif.), 2011-09, Vol.21 (3), p.236-247</ispartof><rights>2011 NATCO: The Organization for Transplant Professionals</rights><rights>Copyright North American Transplant Coordinators Organization Sep 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13</citedby><cites>FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21977885$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shafer, Teresa J.</creatorcontrib><creatorcontrib>Schkade, David</creatorcontrib><creatorcontrib>Schkade, Lawrence</creatorcontrib><creatorcontrib>Geier, Steven S.</creatorcontrib><creatorcontrib>Orlowski, Jeffrey P.</creatorcontrib><creatorcontrib>Klintmalm, Goran</creatorcontrib><title>Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors</title><title>Progress in transplantation (Aliso Viejo, Calif.)</title><addtitle>Prog Transplant</addtitle><description>Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of donors and ruled-out potential donors who had a positive result on an HIV test from January 1, 2006, to October 31, 2008. Sixty-two percent of US organ procurement organizations participated. Of the 12397 donor/nondonor cases, 56 (0.45%) had an initial positive result on an HIV antibody or HIV nucleic acid test, and only 8 (14.3%) of those were confirmed positive. Of the false-positive results, 50% were from HIV antibody tests and 50% were from HIV nucleic acid tests. Organs are a scarce, finite, and perishable resource. Use of HIV antibody testing has produced a remarkably safe track record of avoiding HIV transmission, with 22 years of nonoccurrence between transmissions. Because false positives occur with any test, including the HIV Ab test, adding nucleic acid testing to the standard donor testing panel doubles the number of false-positive HIV test results and thus the number of medically suitable donors lost. The required HIV antibody test is 99.99% effective in preventing transmission of the HIV virus. Adding the HIV nucleic acid test to routine organ donor screening could result in as many as 761 to 1551 unnecessary deaths of patients between HIV transmission events because medically suitable organs are wasted.</description><subject>AIDS Serodiagnosis</subject><subject>Cost-Benefit Analysis</subject><subject>False Positive Reactions</subject><subject>Health Policy</subject><subject>HIV Infections - prevention &amp; control</subject><subject>HIV Infections - transmission</subject><subject>Humans</subject><subject>Nucleic Acid Amplification Techniques</subject><subject>Risk Assessment</subject><subject>Tissue and Organ Procurement</subject><subject>Tissue Donors - supply &amp; distribution</subject><subject>United States</subject><issn>1526-9248</issn><issn>2164-6708</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kctuEzEUhi0EomngBVhUFhtWQ308nozdXZXSixRRhAILNiPbY0duZ-xgj5H6DH3pOk0BqUgsjqwjf-c_lx-hd0A-ArTtMTR0ISjjAIQCITURL9CMwoJVi5bwl2i2A6odcYAOU7ohhLaMk9fogIJoW86bGbr_YWLAX126xeswmCi9NngZ0pTwyv0y6QSvQko4WLwuf2k7SD9JNRh8HTclx2fZ4CngyzxKj6_GMfvQG-u0M17f4e8u5oQ_Zz0Yp_Gpdj1emzQ5v9kpfgmT8ZOTAz4LPsT0Br2yckjm7dM7R9_OP62Xl9Xq-uJqebqqNAUmKkZkw2rCSM1ZTcsqqoQlFlplOeubRiumGhCNlr0FDgp6wjSntaqVEhbqOfqw193G8DOXebrRJW2GspsJOXVcLDgVvDSYo_fPyJuQoy_DFejxmFQUiO4hHcuporHdNrpRxrsOSLczqvvXqFJ09KSc1Wj6PyW_nSnA8R5IcmP-tv2P5APqApqa</recordid><startdate>201109</startdate><enddate>201109</enddate><creator>Shafer, Teresa J.</creator><creator>Schkade, David</creator><creator>Schkade, Lawrence</creator><creator>Geier, Steven S.</creator><creator>Orlowski, Jeffrey P.</creator><creator>Klintmalm, Goran</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>201109</creationdate><title>Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors</title><author>Shafer, Teresa J. ; Schkade, David ; Schkade, Lawrence ; Geier, Steven S. ; Orlowski, Jeffrey P. ; Klintmalm, Goran</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>AIDS Serodiagnosis</topic><topic>Cost-Benefit Analysis</topic><topic>False Positive Reactions</topic><topic>Health Policy</topic><topic>HIV Infections - prevention &amp; control</topic><topic>HIV Infections - transmission</topic><topic>Humans</topic><topic>Nucleic Acid Amplification Techniques</topic><topic>Risk Assessment</topic><topic>Tissue and Organ Procurement</topic><topic>Tissue Donors - supply &amp; distribution</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shafer, Teresa J.</creatorcontrib><creatorcontrib>Schkade, David</creatorcontrib><creatorcontrib>Schkade, Lawrence</creatorcontrib><creatorcontrib>Geier, Steven S.</creatorcontrib><creatorcontrib>Orlowski, Jeffrey P.</creatorcontrib><creatorcontrib>Klintmalm, Goran</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in transplantation (Aliso Viejo, Calif.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shafer, Teresa J.</au><au>Schkade, David</au><au>Schkade, Lawrence</au><au>Geier, Steven S.</au><au>Orlowski, Jeffrey P.</au><au>Klintmalm, Goran</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors</atitle><jtitle>Progress in transplantation (Aliso Viejo, Calif.)</jtitle><addtitle>Prog Transplant</addtitle><date>2011-09</date><risdate>2011</risdate><volume>21</volume><issue>3</issue><spage>236</spage><epage>247</epage><pages>236-247</pages><issn>1526-9248</issn><eissn>2164-6708</eissn><coden>PTRRBT</coden><abstract>Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of donors and ruled-out potential donors who had a positive result on an HIV test from January 1, 2006, to October 31, 2008. Sixty-two percent of US organ procurement organizations participated. Of the 12397 donor/nondonor cases, 56 (0.45%) had an initial positive result on an HIV antibody or HIV nucleic acid test, and only 8 (14.3%) of those were confirmed positive. Of the false-positive results, 50% were from HIV antibody tests and 50% were from HIV nucleic acid tests. Organs are a scarce, finite, and perishable resource. Use of HIV antibody testing has produced a remarkably safe track record of avoiding HIV transmission, with 22 years of nonoccurrence between transmissions. Because false positives occur with any test, including the HIV Ab test, adding nucleic acid testing to the standard donor testing panel doubles the number of false-positive HIV test results and thus the number of medically suitable donors lost. The required HIV antibody test is 99.99% effective in preventing transmission of the HIV virus. Adding the HIV nucleic acid test to routine organ donor screening could result in as many as 761 to 1551 unnecessary deaths of patients between HIV transmission events because medically suitable organs are wasted.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>21977885</pmid><doi>10.1177/152692481102100309</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1526-9248
ispartof Progress in transplantation (Aliso Viejo, Calif.), 2011-09, Vol.21 (3), p.236-247
issn 1526-9248
2164-6708
language eng
recordid cdi_proquest_miscellaneous_896829840
source Sage Journals Online
subjects AIDS Serodiagnosis
Cost-Benefit Analysis
False Positive Reactions
Health Policy
HIV Infections - prevention & control
HIV Infections - transmission
Humans
Nucleic Acid Amplification Techniques
Risk Assessment
Tissue and Organ Procurement
Tissue Donors - supply & distribution
United States
title Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A24%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zero%20Risk%20Tolerance%20Costs%20Lives:%20Loss%20of%20Transplantable%20Organs%20Due%20to%20Human%20Immunodeficiency%20Virus%20Nucleic%20Acid%20Testing%20of%20Potential%20Donors&rft.jtitle=Progress%20in%20transplantation%20(Aliso%20Viejo,%20Calif.)&rft.au=Shafer,%20Teresa%20J.&rft.date=2011-09&rft.volume=21&rft.issue=3&rft.spage=236&rft.epage=247&rft.pages=236-247&rft.issn=1526-9248&rft.eissn=2164-6708&rft.coden=PTRRBT&rft_id=info:doi/10.1177/152692481102100309&rft_dat=%3Cproquest_cross%3E896829840%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=892748029&rft_id=info:pmid/21977885&rft_sage_id=10.1177_152692481102100309&rfr_iscdi=true